Next Article in Journal / Special Issue
An Improved Comprehensive Medication Review Process to Assess Healthcare Outcomes in a Rural Independent Community Pharmacy
Previous Article in Journal
Prescribing Patterns of Antihypertensive Medications in US Ambulatory Care Settings
Previous Article in Special Issue
Alignment of Community Pharmacy Foundation Grant Funding and the Evolution of Pharmacy Practice in the United States of America
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle

An Ethical Analysis of Pharmacy Benefit Manager (PBM) Practices

College of Pharmacy and Health Sciences, Drake University, Des Moines, IA 50311, USA
*
Author to whom correspondence should be addressed.
Pharmacy 2019, 7(2), 65; https://doi.org/10.3390/pharmacy7020065
Received: 29 April 2019 / Revised: 7 June 2019 / Accepted: 11 June 2019 / Published: 14 June 2019
(This article belongs to the Special Issue Pharmacist Services)
  |  
PDF [265 KB, uploaded 14 June 2019]

Abstract

The high costs associated with pharmaceuticals and the accompanying stakeholders are being closely evaluated in the search for solutions. As a major stakeholder in the U.S. pharmaceutical market, the practices of pharmacy benefit manager (PBM) organizations have been under increased scrutiny. Examples of controversial practices have included incentives driving formulary status and prohibiting pharmacists from disclosing information on lower-cost prescription alternatives. Ethical investigations have been largely omitted within the debate on the responsibilities of these organizations in the health care system. Ethical analysis of organizational practices is justified based on the potential impact during health care delivery. The objective of this study was to analyze several specific PBM practices using multiple ethical decision-making models to determine their ethical nature. This study systematically applied multiple ethical decision-making models and codes of ethics to a variety of practices associated with PBM-related dilemmas encountered in the pharmaceutical environment. The assessed scenarios resulted in mixed outcomes. PBM practices were both ethical and unethical depending on the applied ethical model. Despite variation across applied models, some practices were predominately ethical or unethical. The point of sale rebates were consistently determined as ethical, whereas market consolidation, gag clauses, and fluctuation of pharmacy reimbursements were all predominantly determined as unethical. The application of using provider codes of ethics created additional comparison and also contained mixed findings. This study provided a unique assessment of PBM practices and provides context from a variety of ethical perspectives. To the knowledge of the authors, these perspectives have not been previously applied to PBM practices in the literature. The application of ethical decision-making models offers a unique context to current health care dilemmas. It is important to analyze health care dilemmas using ethics-based frameworks to contribute solutions addressing complexities and values of all stakeholders in the health care environment. View Full-Text
Keywords: pharmacy benefit manager (PBM); ethics; pharmaceutical regulation; health care policy; decision-making; organizations; ethical models; code of ethics; pharmacist pharmacy benefit manager (PBM); ethics; pharmaceutical regulation; health care policy; decision-making; organizations; ethical models; code of ethics; pharmacist
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Drettwan, J.J.; Kjos, A.L. An Ethical Analysis of Pharmacy Benefit Manager (PBM) Practices. Pharmacy 2019, 7, 65.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top